Welcome to our dedicated page for Bioceres Crop Solutions news (Ticker: BIOX), a resource for investors and traders seeking the latest updates and insights on Bioceres Crop Solutions stock.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) regularly issues news and updates that reflect its role in agricultural biotechnology, crop inputs and sustainable farming practices. Company announcements frequently describe new developments in its crop protection, seed and integrated products, and crop nutrition segments, as well as progress on its HB4 technology platform and biological solutions.
Investors and industry followers can use this news feed to monitor Bioceres’ financial performance, including quarterly and full-year results prepared under IFRS. Earnings releases typically cover revenues by segment, gross profit and margin trends, operating profit or loss, net income or loss and Adjusted EBITDA, along with commentary on working capital, cash flow and cost structure adjustments.
Bioceres’ news also highlights technology and regulatory milestones. Recent communications include the EPA registration of the Rinotec insecticide and nematicide platform in the United States, commercialization approvals in Brazil, and patent protection for HB4 wheat in the U.S. until 2042. The company has also reported a strategic collaboration with the Colorado Wheat Research Foundation to develop and commercialize HB4 wheat in the United States under an open licensing model.
Corporate governance and financing developments appear in the company’s updates as well, such as changes to the Board of Directors and senior management, amendments to note purchase agreements, and disclosures related to noteholder communications and litigation. By following this page, readers can track how Bioceres communicates its segment performance, capital structure actions and progress on its biotech and biological platforms across key agricultural markets.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will participate in the ROTH 8th Annual London Conference from June 21-23, 2022, held at the InterContinental London Park Lane. CEO Federico Trucco and CFO Enrique Lopez Lecube are set to engage in one-on-one meetings to discuss the company’s fiscal Q3 2022 financial results and its merger agreement with Marrone Bio Innovations. For details about the conference or to connect with the company, interested parties can contact ROTH representatives or reach out via email.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a strong fiscal third quarter 2022, with comparable revenues rising 72% to $60.1 million. The company achieved key regulatory approval for HB4 Soy in China, enabling commercialization in multiple countries. EBITDA targets for HB4 Soy in FY25 are projected at $20-25 million. Additionally, HB4 Wheat received approval in Colombia, Australia, and New Zealand, with expected revenues of $10-12 million for the upcoming planting season. The merger with Marrone Bio Innovations is set to close in Q1 FY23.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is set to discuss its fiscal Q3 2022 results on May 12, 2022, at 8:30 a.m. EDT. The call will be hosted by CEO Federico Trucco, CFO Enrique Lopez Lecube, and Head of Investor Relations Rodrigo Krause. It will include a presentation and a Q&A session. The company aims to support the transition towards carbon-neutral agriculture with its biotech solutions focused on crop productivity. A replay will be available until May 17, 2022.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced that China’s Ministry of Agriculture has approved the import and use of soybeans produced with its HB4® drought-tolerant technology. This clearance allows for the unrestricted commercialization of HB4® soy, which has already been approved in Argentina, the U.S., Canada, Brazil, and Paraguay, covering approximately 85% of the global soybean trade. Bioceres plans to elaborate on the impact of this approval in its financial results conference call on May 12 at 8:30 am EDT.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) have announced a definitive agreement to merge in an all-stock transaction valued at approximately
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will attend the 34th Annual ROTH Conference from March 13-15, 2022, at The Ritz Carlton in Laguna Niguel, California. CFO Enrique López Lecube will participate in one-on-one meetings to discuss the company's recent fiscal results for Q2 2022, its HB4 program, and future milestones. This event provides a platform for Bioceres to engage with investors and highlight its innovations aimed at achieving carbon neutrality in agriculture.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a strong fiscal second quarter 2022, with comparable revenues increasing 89% YoY to $90.3 million and LTM Adjusted EBITDA hitting $61.8 million, up 46%. Revenue growth was driven by inoculants, seed treatments, and micro-beaded fertilizers. The company anticipates peak revenue from HB4 Wheat at $195 million and an EBITDA target of $15-20 million for FY2024. The successful regulatory approval for HB4 wheat flour in Brazil marks a crucial step for commercial launch, with inventories stabilizing towards market demand.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) will hold a conference call on February 10, 2022, at 8:30 a.m. EST to discuss its fiscal Q2 results for the period ending December 31, 2021. Key executives, including Chairman & CEO Federico Trucco, will present the financial results and engage in a Q&A session. Investors can access the call via a toll-free number or webcast. Details regarding access and a replay of the call will be provided, showcasing Bioceres' commitment to transparent communication with stakeholders.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced the successful completion of a $20 million public offering of Series VII corporate bonds by its subsidiary Rizobacter Argentina S.A. The bonds, maturing in December 2024, offer an annual interest rate of 1.49%. Proceeds will be allocated to working capital, building HB4 inventories, and for general corporate purposes, aiming to extend debt maturities and lower financing costs.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is set to participate in two key investor conferences in November and December 2021. The Roth 10th Annual Technology & Inaugural AgTech Answers Virtual Event will occur from November 16-18, featuring one-on-one meetings with CFO Enrique López Lecube. Additionally, Bioceres will present at the Canaccord Genuity AgriFood Tech Innovation Forum on December 2, where López Lecube will also host a virtual presentation. These events aim to highlight Bioceres' role in advancing sustainable agricultural practices.
FAQ
What is the current stock price of Bioceres Crop Solutions (BIOX)?
What is the market cap of Bioceres Crop Solutions (BIOX)?
